The efficacy and safety of furmonertinib in patients with advanced EGFR-mutated NSCLC and leptomeningeal metastases. This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I. This abstract ...
Disparities in glioblastoma care: Insights from a nationwide survey. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does not include a full text component.
First-degree relatives experienced an MS incidence of 211 per 100,000 per year, roughly 100-fold above sporadic MS rates, with median 2-year time to conversion and diagnosis at 37. Evolving ...
Objectives Youth football players are vulnerable to apophyseal injuries, which can have long-term consequences for health and performance. The objective was to assess the incidence, severity and ...